|
|
Article: Columbia Laboratories Closes Registered Direct Common Stock and Warrant Offering.
- Article from:
- Women's Health Weekly
- Article date:
- November 12, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Columbia Laboratories, Inc. (Nasdaq: CBRX) has raised approximately $11,772,000 in gross proceeds to the Company through the sale of 10,900,000 shares of its common stock and warrants to purchase 5,450,000 shares of its common stock in a registered direct offering. The common stock and warrants were sold in units, with each unit consisting of one share of common stock and a warrant to purchase 0.5 shares of common stock at a price of $1.08 per unit in a registered direct offering. The warrants will be exercisable at an exercise price of $1.52 per share of common stock at any time on or after April 30, 2010 and ending on April 30, 2015. Net proceeds to the Company are ...
Related newspaper, magazine, and journal articles:
|
|
Article: Columbia Laboratories Raises $26.3 Million Through ...
PR Newswire;
July 24, 2003 ;
700+ words
...Columbia Laboratories announced today that ... 783 shares of its Common Stock at $11.70 per share ... investors," stated Columbia Laboratories CEO, President and ... statement relating to the Common Stock has been declared effective ...
|
|